International Clinical Trials in Pulmonary/Respiratory Diseases

Argentina

• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Buenos Aires ; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Ciudadela; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Córdoba; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Granadero Baigorria; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Parana; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Rosario; Research Site:
  
  

Australia

• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Fitzroy; Research Site:
  
  

Belgium

• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Leuven; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Aalst; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Bruxelles; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Edegem; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Leuven; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Aalst; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Bruxelles; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Leuven; Research Site:
  
  

Bulgaria

• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Pleven; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Ruse; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Sofia; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Plovdiv; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Sofia; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Ruse; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Sofia; Research Site:
  
  

Canada

• Allergy: A Safety and Efficacy Study of Xolair in Peanut Allergy
  Ontario; Research Site
  
  
• Allergy: A Safety and Efficacy Study of Xolair in Peanut Allergy
  Quebec; Research Site
  
  
• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Toronto, ON; Research Site:
  
  
• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Vancouver, BC; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
  Coquitlam, BC; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Saskatoon, SK; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Winnipeg, MB; Research Site:
  
  

Chile

• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Santiago; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Valdivia; Research Site:
  
  

Croatia

• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Zagreb; Research Site:
  
  

Czech Republic

• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Karlovy Vary; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Ostrava; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Praha; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Tabor; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Brno; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Plzen; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Praha; Research Site:
  
  

Denmark

• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Hellerup; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
  Aalborg; Research Site:
  
  

Estonia

• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Tallinn; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Tartu; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Tallinn; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Tartu; Research Site:
  
  

France

• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Paris; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Toulouse; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Tours; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Paris; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Toulouse; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Tours; Research Site:
  
  

Germany

• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Marburg; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Aachen; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Heidelberg; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  München; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Aachen; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Berlin; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Essen; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Hamburg; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Heidelberg; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  München; Research Site:
  
  

Greece

• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Athens; Research Site:
  
  

Hungary

• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Balassagyarmat; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Budapest; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Pecs; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Szombathely; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Torokbalint; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Budapest; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Pecs; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Szeged; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Budapest; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Pecs; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Szeged; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Budapest; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Nyiregyhaza; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Torokbalint; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Zalaegerszeg; Research Site:
  
  

Iceland

• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Reykjavik; Research Site:
  
  

Israel

• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Ashkelon; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Haifa; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Petah Tikva; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Ramat Gan; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Rehovot; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Tel Aviv; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Jerusalem; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Petah Tikva; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Ramat Gan; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Haifa; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Jerusalem; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Petah Tikva; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Ramat Gan; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Tel Aviv; Research Site:
  
  

Italy

• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Genova; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Modena; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Pavia; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Pisa; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Trieste; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Pavia; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Padova; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Pavia; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Roma; Research Site:
  
  

Latvia

• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Daugavpils; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Riga; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Daugavpils; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Riga; Research Site:
  
  

Lithuania

• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Kaunas; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Vilnius; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Kaunas; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Vilnius; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Kaunas; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Klaipeda; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Vilnius; Research Site:
  
  

Netherlands

• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Almelo; Research Site:
  
  
• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Leiden; Research Site:
  
  
• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Maastricht; Research Site:
  
  

New Zealand

• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Otahuhu; Research Site:
  
  

Peru

• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Lima; Research Site:
  
  

Poland

• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Bialystok; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Katowice; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Lodz; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Poznan; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Warszawa; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Bialystok; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Lodz; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Szczecin; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Warszawa; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Wroclaw; Research Site:
  
  

Portugal

• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Coimbra; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Porto; Research Site:
  
  

Romania

• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Bucharest; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Bucharest; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Constanta; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Craiova; Research Site:
  
  

Slovakia

• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Banska Bystrica; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Nitra; Research Site:
  
  
• Pneumonia: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
  Poprad; Research Site:
  
  

South Africa

• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Amanzimtoti; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Bellville; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Bloemfontein; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Cape Town; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Centurion; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Durban; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Worcester; Research Site:
  
  

Spain

• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Barakaldo; Research Site:
  
  
• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Vigo; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Madrid; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Barcelona; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Madrid; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Madrid; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Santander; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Santiago; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Valladolid; Research Site:
  
  
• Sleep Apnea Sydromes: A Study of the Effect of CPAP in Patients With Diastolic Heart Failure and Sleep-Related Breathing Disorder.
  Vitoria; Research Site:
  
  

Sweden

• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Malmoe; Research Site:
  
  

Switzerland

• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Zürich; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Zürich; Research Site:
  
  

Ukraine

• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Dnipropetrovs'K; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Donetsk; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Kiev; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Kiev; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Lugnansk; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Zaporozhye; Research Site:
  
  

United Kingdom

• Allergy: A Safety and Efficacy Study of Xolair in Peanut Allergy
  Various Cities; Research Site
  
  
• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Birmingham; Research Site:
  
  
• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Cambridge; Research Site:
  
  
• Emphysema: REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
  Edinburgh; Research Site:
  
  
• Emphysema: TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
  Coventry; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Birmingham; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Nottingham; Research Site: